BLSM SCHEDULE 13D: SEC filing

Cormorant entities and Bihua Chen

Filed with the SEC on · accession 0000929638-26-003026

BLSM filed a SCHEDULE 13D (schedule 13d) with the SEC on Aug 13, 2026. Cormorant entities and Bihua Chen filed a Joint Filing Agreement as an exhibit to a Schedule 13D regarding their beneficial ownership of BlossomHill Therapeutics common stock. The stock moved +0.7% by the first close after the filing.

Summary of the filing

Cormorant entities and Bihua Chen filed a Joint Filing Agreement as an exhibit to a Schedule 13D regarding their beneficial ownership of BlossomHill Therapeutics common stock. The agreement allows the filers to submit a single combined Schedule 13D/13G filing.

Key details

Subject company of the schedule 13dBlossomHill Therapeutics, Inc.
Reporting person / filerCormorant Global Healthcare Master Fund, LP
Reporting person / filerCormorant Private Healthcare Fund III, LP
Reporting person / filerCormorant Private Healthcare Fund V, LP
Reporting person / filerCormorant Private Healthcare Fund VI, LP
Reporting person / filerCormorant Asset Management, LP
Managing member of cormorant entitiesBihua Chen

How BLSM stock reacted

Close before

$16.24

Aug 12, 2026

First close after

+0.68%

$16.35

5 trading days

-0.43%

$16.17

Since filing

-16.87%

$13.50

✦ Ask GOAX AI about this filing — what it means for BLSM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BLSM?

Click here

Frequently asked questions

What did BLSM file with the SEC on Aug 13, 2026?

BLSM filed a SCHEDULE 13D (SEC filing). Cormorant entities and Bihua Chen filed a Joint Filing Agreement as an exhibit to a Schedule 13D regarding their beneficial ownership of BlossomHill Therapeutics common stock. The agreement allows the filers to submit a single combined Schedule 13D/13G filing.

How do I read a SCHEDULE 13D?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).

How did BLSM stock react to this filing?

BLSM closed at $16.24 before the filing and $16.35 on Aug 13, 2026 (+0.68%). Five trading days later: $16.17 (-0.43%).

Other BLSM SEC filings

Get alerts when BLSM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days